Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View
Author(s) -
Martin Rössle,
Birke Bausch,
Christoph Klinger
Publication year - 2014
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000370053
Subject(s) - medicine , portal vein thrombosis , transjugular intrahepatic portosystemic shunt , cirrhosis , liver transplantation , portal hypertension , vitamin k antagonist , surgery , transplantation , thrombosis , asymptomatic , gastroenterology , warfarin , atrial fibrillation
Treatment of non-malignant portal vein thrombosis (PVT) in patients with cirrhosis has been neglected in the past because of the fear of bleeding complications when using anticoagulation and due to the technical difficulties associated with the implantation of the transjugular intrahepatic portosystemic shunt (TIPS). However, PVT has a negative impact on outcome and compromises liver transplantation, warranting treatment by using anticoagulation and TIPS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom